Design and rationale for the ASSOS study: Appropriateness of aspirin use in medical outpatients a multicenter and observational study

dc.authoridDemir, Vahit/0000-0001-8349-6651
dc.authoridHidayet, Şıho/0000-0002-4103-9345
dc.authoridTAYLAN, GOKAY/0000-0002-7015-4537
dc.authoridBAŞARAN, ÖZCAN/0000-0002-6384-6455
dc.authoridBekar, Lutfu/0000-0002-3920-1382;
dc.authorwosidDemir, Vahit/P-5623-2019
dc.authorwosidHidayet, Şıho/ABI-2256-2020
dc.authorwosidTAYLAN, GOKAY/HJZ-4693-2023
dc.authorwosidBAŞARAN, ÖZCAN/H-4217-2019
dc.authorwosidBekar, Lutfu/A-6945-2019
dc.authorwosiddemirci, erkan/IVH-2862-2023
dc.authorwosidÖZLEK, BÜLENT/JLL-5279-2023
dc.contributor.authorCelik, Oguzhan
dc.contributor.authorCil, Cem
dc.contributor.authorOzlek, Bulent
dc.contributor.authorOzlek, Eda
dc.contributor.authorDogan, Volkan
dc.contributor.authorBasaran, Ozcan
dc.contributor.authorDemirci, Erkan
dc.date.accessioned2024-08-04T20:09:57Z
dc.date.available2024-08-04T20:09:57Z
dc.date.issued2018
dc.departmentİnönü Üniversitesien_US
dc.description.abstractObjective: The aim of this study was to describe the current status of aspirin use and the demographic characteristics of patients on aspirin for primary and secondary prevention of cardiovascular diseases. Methods: The Appropriateness of Aspirin Use in Medical Outpatients: A Multicenter, Observational Study (ASSOS) trial was a multicenter, cross-sectional, and observational study conducted in Turkey. The study was planned to include 5000 patients from 14 cities in Turkey. The data were collected at one visit, and the current clinical practice regarding aspirin use was evaluated (ClinicalTrials.gov number NCT03387384). Results: The study enrolled all consecutive patients who were admitted to the outpatient cardiology clinics from March 2018 until June 2018. Patients should be at least 18 years old, have signed written informed consent, and on aspirin (80-325 mg) therapy within the last 30 days. Cardiologists from the hospital participates in the study. Patients were divided into 2 categories according to presence or absence of atherosclerotic cardiovascular disease, namely secondary prevention group and primary prevention group, respectively. The appropriate use of aspirin in the primary and secondary prevention groups was assessed according to the European Society of Cardiology guidelines and US Preventive Services Task Force. The patients' gastrointestinal bleeding risk factors and colorectal cancer risk were evaluated. Conclusion: The ASSOS registry will be the most comprehensive and largest study in Turkey evaluating the appropriateness of aspirin use. The results of this study help understand the potential misuse of aspirin in a real-world setting.en_US
dc.identifier.doi10.14744/AnatolJCardiol.2018.47587
dc.identifier.endpage362en_US
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue6en_US
dc.identifier.pmid30504736en_US
dc.identifier.scopus2-s2.0-85058753284en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage354en_US
dc.identifier.trdizinid370291en_US
dc.identifier.urihttps://doi.org/10.14744/AnatolJCardiol.2018.47587
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/370291
dc.identifier.urihttps://hdl.handle.net/11616/92521
dc.identifier.volume20en_US
dc.identifier.wosWOS:000456198000009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofAnatolian Journal of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectaspirinen_US
dc.subjectprimary preventionen_US
dc.subjectoutpatientsen_US
dc.subjectsecondary preventionen_US
dc.titleDesign and rationale for the ASSOS study: Appropriateness of aspirin use in medical outpatients a multicenter and observational studyen_US
dc.typeArticleen_US

Dosyalar